Synthesis reveals potential therapeutic effects of okeaniamide A against diabetes and obesity, highlighting its significant properties.
The stereoselective total synthesis of okeaniamide A, a marine lipopeptide with therapeutic potential against diabetes mellitus and obesity, has been disclosed for the first time. The salient synthetic features include Negishi reaction, Kumada coupling, Julia-Kocienski olefination, and Crimmins acetate aldol reaction. Extension of the polyketide segment to the full molecular framework was achieved through consecutive peptide coupling, followed by late-stage oxidation at position C2. Okeaniamide A was found to be sensitive to C3 epimerization, particularly under oxidative and mildly acidic conditions.
No takes yet. Share an insight, caveat, or question.
Bhaskar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: